{"url_path":"/sec/pahc/8-k/2026-06-26/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1069899/0001104659-26-078323-index.html","accession_number":"0001104659-26-078323","cik":"0001069899","ticker":"PAHC","issuer_name":"PHIBRO ANIMAL HEALTH CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1069899/0001104659-26-078323-index.html","primary_entity_key":"0001069899","primary_entity_name":"PHIBRO ANIMAL HEALTH CORP"},"word_count":318,"has_tables":true,"body_markdown":"false\n0001069899\n\n0001069899\n\n2026-06-25\n2026-06-25\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWASHINGTON, DC 20549**\n\n** **\n\n****\n\n \n\n****\n\n** **\n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**PURSUANT TO SECTION 13 OR 15(D) OF THE**\n\n**SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nDate of report (Date of earliest event reported): June 26, 2026 (June 25, 2026)\n\n \n\n**Phibro Animal Health Corporation**\n\n \n\n(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)\n\n \n\n**Delaware**\n \n**01-36410**\n \n**13-1840497**\n\n**(State or other jurisdiction\nof incorporation)**\n \n**(Commission File Number)**\n \n**(IRS Employer Identification No.)**\n\n \n\n**Glenpointe Centre East, 3rd Floor**\n\n**300 Frank W. Burr Boulevard, Suite 21**\n\n**Teaneck****,\nNew Jersey****07666-6712**\n\n \n\n**(Address of Principal Executive Offices, including\nZip Code)**\n\n \n\n**(201****)\n329-7300**\n\n \n\n**(Registrant’s telephone number, including\narea code)**\n\n** **\n\n**Not Applicable**\n\n \n\n****\n\n**(Former name or former address, if changed\nsince last report)**\n\n \n\n**Securities registered\npursuant to Section 12(b) of the Act:**\n\n \n\n**Title\nof each class**\n \n**Trading\nsymbol(s)**\n \n**Name\nof each exchange on which registered**\n\n**Class A Common Stock, $0.0001 par value per share**\n \n**PAHC**\n \n**Nasdaq\nStock Market**\n\n \n\nCheck the appropriate box below if this Form 8-K\nfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n¨Written\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n¨Soliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n ** **\n\nIndicate by check mark\nwhether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule\n12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).\n\n \n\nEmerging\ngrowth company ¨\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ¨"}